PEPTONIC Financial Statements From 2010 to 2025
| 28L Stock | 0.0002 0.00 0.00% |
Check PEPTONIC MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PEPTONIC MEDICAL's main balance sheet or income statement drivers, such as , as well as many indicators such as . PEPTONIC financial statements analysis is a perfect complement when working with PEPTONIC MEDICAL Valuation or Volatility modules.
PEPTONIC |
PEPTONIC MEDICAL Company Gross Profit Analysis
PEPTONIC MEDICAL's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current PEPTONIC MEDICAL Gross Profit | 19.07 M |
Most of PEPTONIC MEDICAL's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PEPTONIC MEDICAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, PEPTONIC MEDICAL reported 19.07 M of gross profit. This is much higher than that of the sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The gross profit for all Germany stocks is notably lower than that of the firm.
PEPTONIC MEDICAL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PEPTONIC MEDICAL's current stock value. Our valuation model uses many indicators to compare PEPTONIC MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PEPTONIC MEDICAL competition to find correlations between indicators driving PEPTONIC MEDICAL's intrinsic value. More Info.PEPTONIC MEDICAL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PEPTONIC MEDICAL's earnings, one of the primary drivers of an investment's value.About PEPTONIC MEDICAL Financial Statements
PEPTONIC MEDICAL stakeholders use historical fundamental indicators, such as PEPTONIC MEDICAL's revenue or net income, to determine how well the company is positioned to perform in the future. Although PEPTONIC MEDICAL investors may analyze each financial statement separately, they are all interrelated. For example, changes in PEPTONIC MEDICAL's assets and liabilities are reflected in the revenues and expenses on PEPTONIC MEDICAL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PEPTONIC MEDICAL. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in PEPTONIC Stock
PEPTONIC MEDICAL financial ratios help investors to determine whether PEPTONIC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PEPTONIC with respect to the benefits of owning PEPTONIC MEDICAL security.